A Microbial Cocaine Bioreporter.

Escherichia coli Pseudomonas putida ben operon bioluminescence cocaine cocaine esterase microbial bioreporters

Journal

Sensors (Basel, Switzerland)
ISSN: 1424-8220
Titre abrégé: Sensors (Basel)
Pays: Switzerland
ID NLM: 101204366

Informations de publication

Date de publication:
11 Oct 2024
Historique:
received: 01 09 2024
revised: 04 10 2024
accepted: 09 10 2024
medline: 26 10 2024
pubmed: 26 10 2024
entrez: 26 10 2024
Statut: epublish

Résumé

The continuous emergence of new illegal compounds, particularly psychoactive chemicals, poses significant challenges for current drug detection methods. Developing new protocols and kits for each new drug requires substantial time, effort, and dedicated manpower. Whole-cell bacterial bioreporters have been proven capable of detecting diverse hazardous compounds in both laboratory and field settings, identifying not only single compounds but also chemical families. We present the development of a microbial bioreporter for the detection of cocaine, the nervous system stimulant that is the second-most widely used illegal drug in the US.

Identifiants

pubmed: 39460031
pii: s24206549
doi: 10.3390/s24206549
pii:
doi:

Substances chimiques

Cocaine I5Y540LHVR

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Minerva Stiftung
ID : Minerva Center for Biohybrid Complex Systems

Auteurs

Anne-Kathrin Grimm (AK)

Institute of Analytical Chemistry, Chemo- and Biosensors, University of Regensburg, 93053 Regensburg, Germany.

Dor Rozanes (D)

Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.

Etai Shpigel (E)

Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.

Liat Moscovici (L)

Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.

Shimshon Belkin (S)

Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH